The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension
Abstract
OBJECTIVE: To determine the best therapeutic strategy for the use of midodrine in patients with neurogenic orthostatic hypotension (NOH). BACKGROUND: Midodrine is a peripherally acting alpha-adrenergic agonist useful in the treatment of NOH. However, neither the most effective dosage of midodrine nor the required frequency of administration is established. DESIGN/METHODS: Midodrine dose-blood pressure response, pharmacokinetics, and duration of action were examined in a double-blind, placebo-controlled, four-way crossover trial. Twenty-five patients with NOH were randomized to receive on successive days placebo or midodrine 2.5, 10, or 20 mg. Blood pressures of patients in the supine and standing positions were measured sequentially. A global assessment of the patient's overall symptom improvement after each leg of the study was performed. Blood levels of midodrine and its active metabolite, desglymidodrine, were assayed. RESULTS: Midodrine significantly increased standing systolic blood pressure, with the increase peaking at 1 hour. There was a significant linear relation between midodrine dosage and mean systolic blood pressure. The mean score for global improvement of symptoms was significantly higher for midodrine (10 and 20 mg) compared with placebo. The half-life of desglymidodrine was approximately 4 hours. CONCLUSION: A 10-mg dose of midodrine prescribed two to three times daily is effective in increasing orthostatic blood pressure and ameliorating symptoms in patients with NOH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is no doubt that midodrine increases BP both in the supine and upright posture, and ameliorates the symptoms of OH.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [326]
In the citing paper
“Midodrine (2.5-10 mg t.i.d) was shown to be effective in three randomized placebo-controlled trials. 324-326”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [326]
Citations
Cites
Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine
Jankovic, J., Gilden, J. L., Hiner, B. C., Kaufmann, H., Brown, D. C., Coghlan, C. H., Rubin, M., & Fouad-Tarazi, F. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90230-m · Cited by 396
Self-citationMcTavish, D., & Goa, K. L. (1989) · Drugs · doi:10.2165/00003495-198938050-00004 · Cited by 160
Kaufmann, H., Brannan, T. S., Krakoff, L. R., Yahr, M. D., & Mandeli, J. (1988) · Neurology · doi:10.1212/wnl.38.6.951 · Cited by 136
Self-citationPharmacodynamics of midodrine, an antihypotensive agent
Zachariah, P. K., Bloedow, D. C., Moyer, T. P., Sheps, S. G., SCHIRGER, A., & Fealey, R. D. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.101 · Cited by 57
[The bioavailability of midodrin and alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride].
Grobecker, H., Kees, F., Linden, M., Schrader, E., & Welte, S. (1987) · PubMed · Cited by 10
Research works printed but not linked: 5
- Thomas JE, Schirger A. Idiopathic orthostatic hypotension. A study of its natural history in 57 neurologically affected persons. Arch Neurol 1970;22:289-293.
- Cohen J, Low P, Fealey R, Sheps S, Jiang N-S. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol 1987;22:692-699.
- Thulesius O, Gjores JE, Berlin E. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins. Eur J Clin Pharmacol 1979;16:423-424.
- Schatz IJ. Orthostatic hypotension: II. Clinical diagnosis, testing and treatment. Arch Intern Med 1984;144:1037-1041.
- Pittner H, Stormann H, Enzenhofer R. Pharmacodynamic actions of midodrine, a new alpha-adrenergic stimulating agent, and its main metabolite, ST 1059. Arzneimittelforschung 1976;26:2145-2154.
Cited by
Sorted by citations
Items 101–200 of 330
Brien, H. O., & Kenny, R. A. (2014) · European Cardiology Review · doi:10.15420/ecr.2014.9.1.28 · Cited by 41
Chen, J. J., Han, Y., TANG, J. C. Y., Portillo, I., Hauser, R. A., & Dashtipour, K. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018786954 · Cited by 37
Zhu, S., Li, H., Xu, X., Luo, Y., Deng, B., Guo, X., Guo, Y., Yang, W., Wei, X., & Wang, Q. (2021) · Aging and Disease · doi:10.14336/ad.2021.0214 · Cited by 36
Current Concepts in the Treatment of Multiple System Atrophy
Perez‐Lloret, S., Flabeau, O., Fernagut, P., Traon, A. P., Rey, M. V., Foubert‐Samier, A., Tison, F., Rascol, O., & Meissner, W. G. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12145 · Cited by 35
Cardiac Causes for Falls and Their Treatment
Cronin, H., & Kenny, R. A. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.07.006 · Cited by 37
The symptomatic treatment of multiple system atrophy
Colosimo, C., & Pezzella, F. R. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00348.x · Cited by 35
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.005 · Cited by 34
Neurogenic Orthostatic Hypotension: State of the Art and Therapeutic Strategies
Kalra, D. K., Raina, A., & Sohal, S. (2020) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546820953415 · Cited by 33
Treatment of orthostatic hypotension
Oldenburg, O. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00213-8 · Cited by 33
l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy
Gibbons, C. H., Vernino, S. A., Kaufmann, H., & Freeman, R. L. (2005) · Neurology · doi:10.1212/01.wnl.0000178980.83477.14 · Cited by 33
Self-citationAnstey, M., Wibrow, B. A., Thevathasan, T., Roberts, B., Chhangani, K., Ng, P. Y., Levine, A. R., DiBiasio, A., Sarge, T., & Eikermann, M. (2017) · BMC Anesthesiology · doi:10.1186/s12871-017-0339-x · Cited by 33
Exercise-induced hypotension in autonomic disorders
Low, D. A., da Nóbrega, A. C. L., & Mathias, C. J. (2012) · Autonomic Neuroscience · doi:10.1016/j.autneu.2012.07.008 · Cited by 32
Shahidha, R., Al‐Saadi, A. A., & Muthu, S. (2014) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2014.06.033 · Cited by 31
Pharmacological Management of Hemodynamic Complications Following Spinal Cord Injury
McMahon, D. M., Tutt, M., & Cook, A. M. (2009) · Orthopedics · doi:10.3928/01477447-20090502-07 · Cited by 30
Caudate Hemorrhage as a Possible Complication of Midodrine-Induced Supine Hypertension
Sandroni, P., Benarroch, E. E., & Wijdicks, E. F. M. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.12.1275 · Cited by 30
Survival analysis and prognostic nomogram model for multiple system atrophy
Cao, B., Zhang, L., Zou, Y., Wei, Q., Ou, R., Chen, Y., & Shang, H. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.04.016 · Cited by 30
Management of Neurogenic Orthostatic Hypotension in Patients with Autonomic Failure
Schroeder, C., Jordan, J., & Kaufmann, H. (2013) · Drugs · doi:10.1007/s40265-013-0097-0 · Cited by 30
Self-citationCatecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock
Buckley, M. S., Barletta, J. F., Smithburger, P. L., Radosevich, J. J., & Kane‐Gill, S. L. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2199 · Cited by 29
Costa‐Pinto, R., Yong, Z.-T., Yanase, F., Young, C., Brown, A., Udy, A. A., Young, P. J., Eastwood, G. M., & Bellomo, R. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.11.004 · Cited by 29
Disorders of the Autonomic Nervous System
Palma, J., Norcliffe‐Kaufmann, L., Fuente‐Mora, C., Percival, L., Spalink, C. L., & Kaufmann, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00154-5 · Cited by 29
Self-citationEfficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Byun, J., Kim, D., Moon, J., Shin, H., Sunwoo, J., Lee, W. J., Lee, H., Park, K., Lee, S., Jung, K., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50968 · Cited by 29
Heranval, A., Lefaucheur, R., Fetter, D., Rouillé, A., Goff, F. L., & Maltête, D. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2015.11.007 · Cited by 28
Kaufmann, H., Vickery, R. G., Wang, W., Kanodia, J., Shibao, C. A., Norcliffe‐Kaufmann, L., Haumann, B., & Biaggioni, I. (2021) · Clinical Autonomic Research · doi:10.1007/s10286-021-00827-0 · Cited by 27
Self-citationEl‐Azazy, M. (2015) · RSC Advances · doi:10.1039/c5ra05465f · Cited by 27
Orthostatic Hypotension Due to Autonomic Disorders in the Hypertension Clinic
MANSOOR, G. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.09.019 · Cited by 27
Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension
Baker, J. R., & Kimpinski, K. (2017) · CNS Drugs · doi:10.1007/s40263-017-0453-9 · Cited by 26
Management of Orthostatic Hypotension, Postprandial Hypotension, and Supine Hypertension
Shibao, C. A., & Biaggioni, I. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1713886 · Cited by 26
Schrage, W. G., Eisenach, J. H., Dinenno, F. A., Roberts, S. K., Johnson, C. P., Sandroni, P., Low, P. A., & Joyner, M. J. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00547.2004 · Cited by 25
Self-citationEmpfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI
Adams, H. A., Baumann, G., Cascorbi, I., Ebener, C., Emmel, M., Geiger, S., Janssens, U., Klima, U., Klippe, H. J., Knoefel, W. T., et al. (2005) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-005-0576-y · Cited by 25
Duschek, S., Heiss, H., Werner, N. S., & del Paso, G. A. R. (2009) · Hypertension Research · doi:10.1038/hr.2009.115 · Cited by 24
Chemical pharmacotherapy for the treatment of orthostatic hypotension
Cheshire, W. P. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1543404 · Cited by 24
Duschek, S., Heiss, H., Buechner, B., Werner, N. S., Schandry, R., & del Paso, G. A. R. (2009) · The Journal of Physiological Sciences · doi:10.1007/s12576-008-0015-5 · Cited by 23
The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)
Tassone, F., & Berry‐Kravis, E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1 · Cited by 24
New horizons in the ageing autonomic nervous system: orthostatic hypotension and supine hypertension
Dani, M., Taraborrelli, P., Panagopoulos, D., Dirksen, A., Torocastro, M., Sutton, R., & Lim, P. B. (2022) · Age and Ageing · doi:10.1093/ageing/afac150 · Cited by 25
Interventional trials in atypical parkinsonism
Eschlböck, S., Krismer, F., & Wenning, G. K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.038 · Cited by 22
Manual zur Diagnostik und Therapie von Synkopen
von Scheidt, W., Bosch, R., Klingenheben, T., Schuchert, A., Stellbrink, C., & Stockburger, M. (2019) · Der Kardiologe · doi:10.1007/s12181-019-0319-0 · Cited by 21
Soloveva, A. E., Fedorova, D. N., Вадимовна, В. С., Звартау, Н. Э., Mareev, Y., Sitnikova, M. Y., Shlyakhto, E. V., & Fudim, M. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10044-1 · Cited by 21
Vaidyanathan, S., Soni, B. M., & Hughes, P. L. (2007) · Advances in Therapy · doi:10.1007/bf02849965 · Cited by 21
Arnold, A. C., Ramirez, C. E., Choi, L., Okamoto, L. E., Gamboa, A. C., Diedrich, A., Raj, S. R., Robertson, D., Biaggioni, I., & Shibao, C. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00270 · Cited by 21
Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.
Olshansky, B., & Muldowney, J. (2020) · American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.037 · Cited by 22
Drug Treatment of Orthostatic Hypotension Because of Autonomic Failure or Neurocardiogenic Syncope
Lamarre-Cliché, M. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202010-00004 · Cited by 21
Biaggioni, I., & Kaufmann, H. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/00227-6 · Cited by 21
Self-citationMy Treatment Approach to Multiple System Atrophy
Coon, E. A., & Ahlskog, J. E. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.10.005 · Cited by 20
Hammond, D. A., Smith, M. N., Peksa, G. D., Trivedi, A. P., BALK, R. A., & Menich, B. E. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619843279 · Cited by 20
Therapeutic advances in multiple system atrophy and progressive supranuclear palsy
Poewe, W. H., Mahlknecht, P., & Krismer, F. (2015) · Movement Disorders · doi:10.1002/mds.26334 · Cited by 19
Thaisetthawatkul, P. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0673-2 · Cited by 18
Tremblay, J.-A., Laramée, P., Lamarche, Y., Denault, A. Y., Beaubien‐Souligny, W., Frenette, A.-J., Kontar, L., Serri, K., & Charbonney, E. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00737-w · Cited by 19
Duschek, S., Heiss, H., Buechner, B., & Schandry, R. (2009) · Journal of Psychophysiology · doi:10.1027/0269-8803.23.3.104 · Cited by 18
Lee, Y.-J., Kim, H. S., Seo, H. S., Na, J. O., Jang, Y. N., Han, Y.-M., & Kim, H.-M. (2020) · PPAR Research · doi:10.1155/2020/3785137 · Cited by 19
Pharmacological treatment of reflex syncope
Kaufmann, H., & Freeman, R. L. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-1010-4 · Cited by 18
Self-citationLahrmann, H., Cortelli, P., Hilz, M. J., Mathias, C. J., Struhal, W., & Tassinari, M. (2010) · doi:10.1002/9781444328394.ch33 · Cited by 18
Fanciulli, A., Sixel‐Döring, F., Buhmann, C., Krismer, F., Hermann, W., Winkler, C., Woitalla, D., Jost, W. H., German Parkinson’s Guideline Group, Bähr, M., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-024-12730-5 · Cited by 17
Ortíz, J. F., Betté, S., Tambo, W., Tao, F., Cozar, J. C., & Isaacson, S. (2020) · Cureus · doi:10.7759/cureus.10741 · Cited by 17
Isaacson, S., Dashtipour, K., MEHDIRAD, A. A., & Peltier, A. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01104-3 · Cited by 20
Evaluation of syncope: focus on diagnosis and treatment of neurally mediated syncope
Lee, A. K. Y., & Krahn, A. D. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1164034 · Cited by 19
Palma, J., & Kaufmann, H. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1713846 · Cited by 17
Self-citationDiagnosis and Treatment of Neurally Mediated Syncope
Kaufmann, H., & Bhattacharya, K. (2002) · The Neurologist · doi:10.1097/00127893-200205000-00004 · Cited by 17
Self-citationManagement of Neurogenic Orthostatic Hypotension
Arbique, D., Cheek, D. J., Welliver, M. D., & Vongpatanasin, W. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.10.014 · Cited by 17
Hohler, A. D., Amariei, D. E., Katz, D. I., DePiero, T. J., Allen, V., Boyle, S., Phenix, H., DeAngelis, T. A., Geibel, C. D., Smith, K. M., et al. (2012) · Journal of Parkinson s Disease · doi:10.3233/jpd-2012-012101 · Cited by 17
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review)
Khalil, I., Sayad, R., Kedwany, A. M., Sayed, H. H., Caprara, A. L. F., & Rissardo, J. P. (2024) · Medicine International · doi:10.3892/mi.2024.194 · Cited by 19
Recurrent syncope: differential diagnosis and management
Bennett, M. T., Leader, N., & Krahn, A. D. (2015) · Heart · doi:10.1136/heartjnl-2014-306627 · Cited by 17
Management of Orthostatic Hypotension: A Literature Review
Asad, A., Ali, N. S., Waqas, N., Bhan, C., Iftikhar, W., Sapna, F., Jitidhar, F., Cheema, A. M., Ahmad, M. Q., Nasir, U., et al. (2018) · Cureus · doi:10.7759/cureus.3166 · Cited by 16
Management of postural hypotension
Kochar, M. S. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0028-9 · Cited by 16
Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease
Shibao, C. A., & Kaufmann, H. (2017) · CNS Drugs · doi:10.1007/s40263-017-0473-5 · Cited by 15
Self-citationSchimpf, R., Veltmann, C., & Borggrefe, M. (2011) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-011-0132-3 · Cited by 15
Hamed, M., Elseidy, S. A., Elkheshen, A., Maher, J., Elmoghrabi, A., Zaghloul, A., Panakos, A., Panaich, S., Saad, M. S., & Elbadawi, A. (2023) · Cardiology and Therapy · doi:10.1007/s40119-023-00301-0 · Cited by 14
Orthostatic hypotension: Review and expert position statement
Vidal‐Petiot, E., Pathak, A., Azulay, J.-P., Traon, A. P., & Hanon, O. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.11.001 · Cited by 15
Orthostatic hypotension in multiple system atrophy
Riley, D. E. (2000) · Current Treatment Options in Neurology · doi:10.1007/s11940-000-0005-2 · Cited by 14
Management of orthostatic hypotension in patients with Parkinson's disease
Wu, C., & Hohler, A. D. (2014) · Practical Neurology · doi:10.1136/practneurol-2014-001000 · Cited by 14
Akimoto, M., Iida, I., Itoga, H., Miyata, A., Kawahara, S., & Kohno, Y. (2004) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190595 · Cited by 14
Midodrine Efficacy in Orthostatic Hypotension
Singer, W., Joyner, M. J., Sandroni, P., Benarroch, E. E., Fealey, R. D., Mandrekar, J. N., & Low, P. A. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3014-7 · Cited by 14
Self-citationA Practical Guide to the Treatment of Neurogenic Orthostatic Hypotension
Berger, M., & Kimpinski, K. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100016528 · Cited by 14
Treatment of Patients With Orthostatic Hypotension and Syncope
Kaufmann, H. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200205000-00003 · Cited by 13
Self-citationPainful and involuntary multiple sclerosis
Bagnato, F. R., Centonze, D., Galgani, S., Grasso, M. G., Haggiag, S., & Strano, S. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.540239 · Cited by 12
Treatment and Management of FXTAS
Berry‐Kravis, E., Hall, D. A., Leehey, M. A., & Hagerman, R. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1_9 · Cited by 11
Management of Orthostatic Hypotension from Autonomic Dysfunction in Diabetics on Peritoneal Dialysis
Agrawal, A., Saran, R., & Khanna, R. (1999) · Peritoneal Dialysis International · doi:10.1177/089686089901900503 · Cited by 12
A Clinical, Physiology and Pharmacology Evaluation of Orthostatic Hypotension in the Elderly
Sahni, M., Lowenthal, D. T., & Meuleman, J. R. (2005) · International Urology and Nephrology · doi:10.1007/s11255-005-7663-7 · Cited by 12
Midodrine use in critically ill patients: a narrative review
Costa‐Pinto, R., Jones, D. A., Udy, A. A., Warrillow, S. J., & Bellomo, R. (2022) · Critical Care and Resuscitation · doi:10.51893/2022.4.r · Cited by 11
McCarthy, F., Fan, C. W., Kearney, P. M., Walsh, C., & Kenny, R. A. (2010) · European Geriatric Medicine · doi:10.1016/j.eurger.2010.06.003 · Cited by 11
Hemodynamic Effects of an Increased Midodrine Dosing Frequency
Macielak, S. A., Vollmer, N. J., Haddad, N. A., Nabzdyk, C. S., & Nei, S. D. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000405 · Cited by 10
Treatment options for autonomic neuropathies
Gibbons, C. H., & Freeman, R. L. (2006) · Current Treatment Options in Neurology · doi:10.1007/s11940-006-0003-0 · Cited by 10
Autonomic Dysfunction and Hypotension
Mathias, C. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_91 · Cited by 10
Diagnosis and management of neurogenic orthostatic hypotension
Ju, W., & Sinn, D.-I. (2023) · Annals of Clinical Neurophysiology · doi:10.14253/acn.2023.25.2.66 · Cited by 10
Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report
Hale, G. M., & Brenner, M. J. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1635 · Cited by 9
Bird, S. J., & Brown, M. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_31 · Cited by 10
Midodrine, an alternative to intravenous vasopressor therapy after spinal surgery
OʼDonnell, B. D., & Synnott, A. (2002) · European Journal of Anaesthesiology · doi:10.1017/s0265021502251352 · Cited by 9
Pharmacokinetics of Pyridostigmine in a Child With Postural Tachycardia Syndrome
Filler, G., Gow, R. M., Nadarajah, R., Jacob, P. J., Johnson, G., Zhang, Y., & Christians, U. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0904 · Cited by 9
Strategy for the Management of Vasovagal Syncope
Bloomfield, D. M. (2002) · Drugs & Aging · doi:10.2165/00002512-200219030-00003 · Cited by 9
Geser, F., Colosimo, C., & Wenning, G. K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.044 · Cited by 9
Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI
Adams, H. A., Baumann, G., Cascorbi, I., Ebener, C., Emmel, M., Geiger, S., Janssens, U., Klima, U., Klippe, H. J., Knoefel, W. T., et al. (2005) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-005-0575-z · Cited by 9
Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI
Adams, H. A., Baumann, G., Cascorbi, I., Ebener, C., Emmel, M., Geiger, S., Janssens, U., Klima, U., Klippe, H. J., Knoefel, W. T., et al. (2005) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-005-0579-8 · Cited by 9
How to treat cardiovascular autonomic failure in Parkinson’s disease
Fanciulli, A., Leys, F., Höglinger, G. U., & Jost, W. H. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-025-03096-7 · Cited by 8
Guía de práctica clínica para el diagnóstico y manejo del síncope (versión 2009)
Moya‐Mitjans, À., Sutton, R., Ammirati, F., Blanc, J., Brignole, M., Dahm, J. B., Deharo, J., Gajek, J. J., Gjesdal, K., Krahn, A. D., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73132-x · Cited by 23
Self-citationChronic hypotension and modulation of autonomic cardiovascular regulation
Parati, G., Rienzo, M. D., Coruzzi, P., & Castiglioni, P. (2009) · Hypertension Research · doi:10.1038/hr.2009.150 · Cited by 8
Acute dystonia induced by the combination of midodrine and perphenazine
Castrioto, A., Tambasco, N., Rossi, A., & Calabresi, P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0805-y · Cited by 8
Pharmacological options in the management of orthostatic hypotension in older adults
Kearney, F. C., & Moore, A. R. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.130 · Cited by 8
Nonmotor Disorders and Their Correlation With Dopamine
Martínez‐Castrillo, J. C., Vela, L., del Val, J., & Cánovas, A. A. (2011) · The Neurologist · doi:10.1097/nrl.0b013e318239669f · Cited by 8
Kim, T., & Jwa, C. S. (2015) · Korean Journal of Neurotrauma · doi:10.13004/kjnt.2015.11.2.147 · Cited by 8
Chen, B., Yang, W., Luo, Y., Tan, E., & Wang, Q. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11876-y · Cited by 7
Autonomic dysfunction in Parkinson's disease
Kaufmann, H., & Goldstein, D. S. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83014-4 · Cited by 7
Self-citation
Metadata
- Authors
- Wright, R. A., Kaufmann, H. C., Perera, R., Opfer-Gehrking, T. L., McElligott, M. A., Sheng, K. N., & Low, P. A.
- Affiliations
- Mayo Clinic (US)
- Venue
- Neurology
- Published
- 1998-07
- Volume
- 51
- Issue
- 1
- Pages
- 120-124
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2048764982
- Cited by
- 331
- References
- 5
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 8 · 2023: 11 · 2022: 12 · 2021: 14 · 2020: 23 · 2019: 8 · 2018: 16 · 2017: 24 · 2016: 9 · 2015: 16 · 2014: 24 · 2013: 22 · 2012: 5
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Foundation for Medical Education and Research
- National Institutes of Health (1p01ns032352-01a1)
- National Institute of Neurological Disorders and Stroke (P01 NS 32352)
- National Center for Research Resources (5MO RR00071)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- midodrine, neurogenic orthostatic hypotension, alpha-adrenergic agonists, dose-response relationship, pharmacokinetics, blood pressure, symptom improvement
- MeSH terms
- Adrenergic alpha-Agonists, Adult, Aged, Autonomic Nervous System Diseases, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Hypotension, Orthostatic, Male, Middle Aged, Midodrine, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
